BrainsWay Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- BrainsWay Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Jerusalem
- Headquarters country
- Israel
- Ticker symbol
- BWAY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001505065
- Wikidata ID
- Q2913953
Board of directors
-
Abraham Zangen · DirectorSince 2026
-
Amiram Boehm · DirectorSince 2026
-
Avner Lushi · DirectorSince 2026
-
David Zacut · DirectorSince 2026
-
Jonathan K. Shulkin · DirectorSince 2026
-
Karen Sarid · DirectorSince 2026
-
Rayten Michal Ety Mitrany · DirectorSince 2026
Board connections
2 of this board's directors also sit on 2 other boards.
- via Amiram Boehm
- via Avner Lushi
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 7 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Open-market sale | −5,000 | — | — |
| Jun 2, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −1,000 | — | — |
| Jun 2, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| Jun 1, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| Jun 1, 2026 | Roth Yiftach Officer (Chief Scientist) | Open-market sale | −2,000 | — | — |
| May 26, 2026 | Rayten Michal Ety Mitrany Director | Open-market sale | −7,980 | — | — |
| May 25, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Option exercise | +7,500 | — | — |
| May 25, 2026 | Rayten Michal Ety Mitrany Director | Open-market sale | −10,000 | — | — |
| May 25, 2026 | Moiseyev Gilad Officer (Chief Technology Officer) | Shares withheld for tax | −1,902 | — | — |
| May 20, 2026 | Rayten Michal Ety Mitrany Director | Option exercise | +17,500 | — | — |
| May 20, 2026 | Rayten Michal Ety Mitrany Director | Shares withheld for tax | −6,080 | — | — |
| May 19, 2026 | Rayten Michal Ety Mitrany Director | Option exercise | +10,000 | — | — |
| May 19, 2026 | Rayten Michal Ety Mitrany Director | Shares withheld for tax | −3,440 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.